Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medikit CoTSE:7749 -0.25%88 Buyback Yield % is 1.02 as of Jul. 19, 2026, which is 7% above its 10-year median of 0.95. GuruFocus rates TSE:7749 with a GF Score™ of 88/100 and a GF Value™ of 円3,203.49 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 348 Medical Devices & Instruments companies, Medikit Co ranks better than 79.6% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Medikit Co's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7749 vs ISRG, BDX, MDLN: Buyback Yield % Comparison
For the Medical Instruments & Supplies subindustry, Medikit Co's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medikit Co Buyback Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medikit Co's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Medikit Co's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medikit Co (TSE:7749) has a Buyback Yield % of 1.02 as of Jul. 19, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Medikit Co and its competitors. This is near median its historical median of 0.95. Over the past decade, Medikit Co's Buyback Yield % has ranged from 0.17 to 10.87. According to the industry distribution chart, Medikit Co ranks #71 out of 348 companies in the Medical Devices & Instruments industry, placing it in the top 20.4%.
Is Medikit Co's Buyback Yield % too high?
Medikit Co's current Buyback Yield % of 1.02 is near median its 10-year median of 0.95. Over the past 10 years, this metric has ranged from a low of 0.17 to a high of 10.87. Based on the distribution chart, Medikit Co ranks #71 out of 348 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Medikit Co has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medikit Co's Buyback Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Medikit Co ranks #71 out of 348 companies for Buyback Yield %. This places Medikit Co in the top 20% of its industry — outperforming the majority of peers. Historically, Medikit Co's own Buyback Yield % has ranged from 0.17 to 10.87 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Medikit Co and its competitors. Medikit Co's current Buyback Yield % is 1.02, which is near median its own 10-year median of 0.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medikit Co stock overvalued right now?
Based on GuruFocus' analysis, Medikit Co (TSE:7749) is currently considered Modestly Undervalued. The stock's GF Value™ is 円3,203.49, compared to a current price of 円2,778.00 — trading 13.3% below its estimated fair value. The current Buyback Yield % is 1.02, which is near median its 10-year median of 0.95. Medikit Co's overall GF Score™ is 88/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Medikit Co (TSE:7749), the current Buyback Yield % is 1.02 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medikit Co (TSE:7749) Overvalued in 2026?
Based on GuruFocus' analysis, Medikit Co stock appears to be undervalued.
The current stock price of 円2,778.00 is trading 13.3% below its estimated GF Value™ of 円3,203.49.
GuruFocus considers Medikit Co to be Modestly Undervalued.
Key valuation signals for TSE:7749:
Buyback Yield %: 1.02 (near median its 10-year median of 0.95)
GF Value™: 円3,203.49 vs. price of 円2,778.00 (13.3% below fair value)
No single metric tells the full story. See the TSE:7749 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medikit Co Ltd develops, manufactures and sells medical equipment. The company's products offerings are IV Catheter, Hemodialysis, Inner needle, Blood control cap, among others.
88GF Score
Get the complete analysis for TSE:7749
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7749 has been successfully added to your 
